Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

INVO Bioscience, Inc. (INVO)

1.0201   -0.011 (-1.1%) 11-25 12:57
Open: 1.05 Pre. Close: 1.0314
High: 1.06 Low: 1.0201
Volume: 1,133 Market Cap: 12(M)

Technical analysis

as of: 2022-11-25 1:58:02 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.38     One year: 1.51
Support: Support1: 1    Support2: 0.83
Resistance: Resistance1: 1.18    Resistance2: 1.29
Pivot: 1.12
Moving Average: MA(5): 1.1     MA(20): 1.12
MA(100): 1.12     MA(250): 1.86
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 23.6     %D(3): 37.5
RSI: RSI(14): 39.9
52-week: High: 4.05  Low: 0.62
Average Vol(K): 3-Month: 21 (K)  10-Days: 12 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ INVO ] has closed above bottom band by 18.3%. Bollinger Bands are 21.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.13 - 1.14 1.14 - 1.14
Low: 0.99 - 1 1 - 1.01
Close: 1.02 - 1.03 1.03 - 1.04

Company Description

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Headline News

Tue, 22 Nov 2022
Invo Solutions, the nation's first video banking solution, celebrates 10-year anniversary - EIN News

Tue, 22 Nov 2022
Ambarella's AI chips power cabin monitoring systems ... - eeNews Europe

Tue, 15 Nov 2022
INVO Bioscience Earnings Miss, Revenue Beats In Q3 By -

Mon, 14 Nov 2022
INVO Bioscience Misses Q3 EPS by 9c By -

Mon, 14 Nov 2022
INVO Bioscience, Inc. (INVO) Q3 2022 Earnings Call Transcript - Seeking Alpha

Mon, 14 Nov 2022
INVO Bioscience Reports Third Quarter 2022 Financial Results - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 12 (M)
Shares Float 10 (M)
% Held by Insiders 10.2 (%)
% Held by Institutions 10.8 (%)
Shares Short 59 (K)
Shares Short P.Month 69 (K)

Stock Financials

EPS -0.63
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.1
Profit Margin (%) -230.2
Operating Margin (%) -206.2
Return on Assets (ttm) -72.2
Return on Equity (ttm) -440.8
Qtrly Rev. Growth 7.5
Gross Profit (p.s.) 0.33
Sales Per Share 0.29
EBITDA (p.s.) -0.61
Qtrly Earnings Growth 0
Operating Cash Flow -7 (M)
Levered Free Cash Flow -2 (M)

Stock Valuations

PE Ratio -1.65
PEG Ratio 0
Price to Book value 9.36
Price to Sales 3.49
Price to Cash Flow -1.77

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2020-11-08
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.